Mutations in PA3574 (nalD) Lead to Increased MexAB-OprM Expression and Multidrug Resistance in Laboratory and Clinical Isolates of Pseudomonas aeruginosa - Archive ouverte HAL
Article Dans Une Revue Antimicrobial Agents and Chemotherapy Année : 2005

Mutations in PA3574 (nalD) Lead to Increased MexAB-OprM Expression and Multidrug Resistance in Laboratory and Clinical Isolates of Pseudomonas aeruginosa

Résumé

Mutations in genes mexR and nalC have previously been shown to drive overexpression of the MexAB-OprM multidrug efflux system in Pseudomonas aeruginosa. A transposon insertion multidrug-resistant mutant of P. aeruginosa overproducing MexAB-OprM was disrupted in yet a third gene, PA3574, encoding a probable repressor of the TetR/AcrR family that we have dubbed NalD. Clinical strains overexpressing MexAB-OprM but lacking mutations in mexR or nalC were also shown to carry mutations in nalD. Moreover, the cloned nalD gene reduced the multidrug resistance and MexAB-OprM expression of the transposon mutant and clinical isolates, highlighting the significance of the nalD mutations vis-a-vis MexAB-OprM overexpression in these isolates.

Domaines

Bactériologie

Dates et versions

hal-01696230 , version 1 (30-01-2018)

Identifiants

Citer

Mara Sobel, Didier Hocquet, Lily Cao, Patrick Plesiat, Keith Poole. Mutations in PA3574 (nalD) Lead to Increased MexAB-OprM Expression and Multidrug Resistance in Laboratory and Clinical Isolates of Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy, 2005, 49 (5), pp.1782 - 1786. ⟨10.1128/AAC.49.5.1782-1786.2005⟩. ⟨hal-01696230⟩

Collections

UNIV-FCOMTE EPILAB
22 Consultations
0 Téléchargements

Altmetric

Partager

More